Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tranexamic acid for hemorrhage prevention in repeat cesarean delivery
NCT03856164Phase 3Completed
- Sponsor
- UT Southwestern Medical Center
- Start
- Jun 2019
- Primary completion
- Jan 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of tranexamic acid in postpartum hemorrhage (PPH), sponsored by UT Southwestern Medical Center. Primary endpoint: Blood Volume Loss. Started Jun 2019; status: completed.
02
Drugs
tranexamic acid
03
Conditions
postpartum hemorrhage (PPH)
Beyond the preview
Go deeper on NCT03856164.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03856164.